Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1.

Assunto A, Ferrara U, De Luca A, Pivonello C, Lombardo L, Piscitelli A, Tortora C, Pinna V, Daniele P, Pivonello R, Russo MG, Limongelli G, Colao A, Tartaglia M, Strisciuglio P, Melis D.

Orphanet J Rare Dis. 2019 Nov 15;14(1):261. doi: 10.1186/s13023-019-1223-1.

2.

Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit.

Provvisiero DP, Negri M, de Angelis C, Di Gennaro G, Patalano R, Simeoli C, Papa F, Ferrigno R, Auriemma RS, De Martino MC, Colao A, Pivonello R, Pivonello C.

Sci Rep. 2019 Aug 12;9(1):11695. doi: 10.1038/s41598-019-48081-9.

3.

The role of mTOR pathway as target for treatment in adrenocortical cancer.

De Martino MC, Feelders RA, Pivonello C, Simeoli C, Papa FC, Colao AA, Pivonello R, Hofland LJ.

Endocr Connect. 2019 Aug 1. pii: EC-19-0224.R1. doi: 10.1530/EC-19-0224. [Epub ahead of print] Review.

4.

IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer.

De Martino MC, van Koetsveld PM, Feelders RA, de Herder WW, Dogan F, Janssen JAMJL, Hofste Op Bruinink D, Pivonello C, Waaijers AM, Colao A, de Krijger RR, Pivonello R, Hofland LJ.

Endocrine. 2019 Jun;64(3):673-684. doi: 10.1007/s12020-019-01869-1. Epub 2019 Mar 5.

5.

Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting.

Pivonello C, Patalano R, Solari D, Auriemma RS, Frio F, Vitulli F, Grasso LFS, Di Cera M, De Martino MC, Cavallo LM, Cappabianca P, Colao A, Pivonello R.

Endocrine. 2018 Dec;62(3):663-680. doi: 10.1007/s12020-018-1677-2. Epub 2018 Jul 31.

PMID:
30066286
6.

Circadian Rhythm of Glucocorticoid Administration Entrains Clock Genes in Immune Cells: A DREAM Trial Ancillary Study.

Venneri MA, Hasenmajer V, Fiore D, Sbardella E, Pofi R, Graziadio C, Gianfrilli D, Pivonello C, Negri M, Naro F, Grossman AB, Lenzi A, Pivonello R, Isidori AM.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2998-3009. doi: 10.1210/jc.2018-00346.

PMID:
29846607
7.

Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.

Picillo M, Pivonello R, Santangelo G, Pivonello C, Savastano R, Auriemma R, Amboni M, Scannapieco S, Pierro A, Colao A, Barone P, Pellecchia MT.

PLoS One. 2017 Oct 24;12(10):e0186508. doi: 10.1371/journal.pone.0186508. eCollection 2017.

8.

The environment and male reproduction: The effect of cadmium exposure on reproductive function and its implication in fertility.

de Angelis C, Galdiero M, Pivonello C, Salzano C, Gianfrilli D, Piscitelli P, Lenzi A, Colao A, Pivonello R.

Reprod Toxicol. 2017 Oct;73:105-127. doi: 10.1016/j.reprotox.2017.07.021. Epub 2017 Aug 1. Review.

PMID:
28774687
9.

The role of vitamin D in male fertility: A focus on the testis.

de Angelis C, Galdiero M, Pivonello C, Garifalos F, Menafra D, Cariati F, Salzano C, Galdiero G, Piscopo M, Vece A, Colao A, Pivonello R.

Rev Endocr Metab Disord. 2017 Sep;18(3):285-305. doi: 10.1007/s11154-017-9425-0. Review.

PMID:
28667465
10.

Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance.

Muscogiuri G, De Martino MC, Negri M, Pivonello C, Simeoli C, Orio F, Pivonello R, Colao A.

Endocrinology. 2017 Jun 1;158(6):1527-1532. doi: 10.1210/en.2016-1804. Review.

PMID:
28368448
11.

Selenium supplementation modulates apoptotic processes in thyroid follicular cells.

Nettore IC, De Nisco E, Desiderio S, Passaro C, Maione L, Negri M, Albano L, Pivonello R, Pivonello C, Portella G, Ungaro P, Colao A, Macchia PE.

Biofactors. 2017 May 6;43(3):415-423. doi: 10.1002/biof.1351. Epub 2017 Mar 2.

PMID:
28251705
12.

Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.

Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Pivonello R, Pezzullo L, Botti G, Colao A, Faggiano A.

Endocrine. 2017 Sep;57(3):544. doi: 10.1007/s12020-017-1269-6. No abstract available.

PMID:
28243971
13.

Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.

Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, Galdiero M, Colao A.

Pituitary. 2017 Feb;20(1):46-62. doi: 10.1007/s11102-017-0797-7. Review.

PMID:
28224405
14.

Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.

Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Pivonello R, Pezzullo L, Botti G, Colao A, Faggiano A.

Endocrine. 2017 Sep;57(3):539-543. doi: 10.1007/s12020-016-1200-6. Epub 2016 Dec 16. No abstract available. Erratum in: Endocrine. 2017 Feb 27;:.

PMID:
27981515
15.

Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.

Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Gambardella C, Grasso M, Antonino A, Annunziata A, Macchia PE, Pivonello R, Santini L, Botti G, Losito S, Pezzullo L, Colao A, Faggiano A.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):661-671. doi: 10.1210/jc.2016-2555.

PMID:
27849428
16.

Influence of Bisphenol A on Type 2 Diabetes Mellitus.

Provvisiero DP, Pivonello C, Muscogiuri G, Negri M, de Angelis C, Simeoli C, Pivonello R, Colao A.

Int J Environ Res Public Health. 2016 Oct 6;13(10). pii: E989. Review.

17.

Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland.

Pivonello R, Waaijers M, Kros JM, Pivonello C, de Angelis C, Cozzolino A, Colao A, Lamberts SWJ, Hofland LJ.

Endocrine. 2017 Aug;57(2):314-325. doi: 10.1007/s12020-016-1107-2. Epub 2016 Oct 13.

PMID:
27738887
18.

Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.

Pivonello C, Rousaki P, Negri M, Sarnataro M, Napolitano M, Marino FZ, Patalano R, De Martino MC, Sciammarella C, Faggiano A, Rocco G, Franco R, Kaltsas GA, Colao A, Pivonello R.

Endocrine. 2017 Jun;56(3):603-620. doi: 10.1007/s12020-016-1079-2. Epub 2016 Sep 29.

PMID:
27688013
19.

Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment.

Bimonte S, Leongito M, Piccirillo M, de Angelis C, Pivonello C, Granata V, Izzo F.

Infect Agent Cancer. 2016 Aug 12;11:38. doi: 10.1186/s13027-016-0082-9. eCollection 2016. Review.

20.

Curcumin AntiCancer Studies in Pancreatic Cancer.

Bimonte S, Barbieri A, Leongito M, Piccirillo M, Giudice A, Pivonello C, de Angelis C, Granata V, Palaia R, Izzo F.

Nutrients. 2016 Jul 16;8(7). pii: E433. doi: 10.3390/nu8070433. Review.

Supplemental Content

Loading ...
Support Center